BNF:

10.1.3

Status:

Amber

Decision Date:

None

Comments

See shared care guideline for immunomodulating drugs

Amber Drug Classifications

• 1: Requiring specialist assessment to enable patient selection and initiation of treatment
• 2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable

search again